Schrödinger
North America, New York, United States, New York
Description
Schrödinger is a healthcare-based software company that develops molecular design software for biotech and materials research.
Investor Profile
Schrödinger has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Seed (33%)
- Series C (22%)
- Series B (22%)
- Series A (11%)
- Series Unknown (11%)
Country Focus
- United States (89%)
- Canada (11%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Life Science
- Pharmaceutical
- Product Research
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Schrödinger frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Which angels does Schrödinger often collaborate with?
What are some of recent deals done by Schrödinger?
Find More Investors Like Schrödinger
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
